Vaccine Hesitancy in the Sickle Cell Disease/Black Community

COVID-19-Ask-A-Doc| April 28, 2022
Vaccine Hesitancy in the Sickle Cell Disease/Black Community- A Public Health Agency of Canada sponsored study

  • What are some details about the study? - SCAGO
  • How does the study look at vaccine hesitancy differently? - SCAGO
  • What is the goal of the project? - SCAGO
  • By when do you expect your goals to be achieved? - SCAGO
  • How is information for the study gathered? - SCAGO
  • What is your current stage in planning? - SCAGO
  • Are participants outside of Toronto unable to participate in the study? - SCAGO
  • What kinds of participants are you hoping to recruit? - SCAGO
  • Where can one find more information and/or sign-up? - SCAGO
  • Could people with SCD experience less crises with a double dose? - SCAGO
  • How many doses are recommended for those with SCD? - SCAGO
  • What is cross-sectional observation and how is it used in the study? - SCAGO
  • What are the benefits of participating in this kind of study? - SCAGO
  • How will the information collected benefit the community? - SCAGO
  • Can anyone participate in the study? - SCAGO
Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.
Sickle Cell Awareness Group of Ontario